Allopurinol 100 MG Oral Tablet — RxCUI 197319
RxNorm drug concept · Semantic clinical drug
RxCUI 197319
Semantic clinical drug · SCD
● Current RxNorm concept 104 FDA products
265 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197319
Official nameAllopurinol 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped104
Package NDCs mapped265
Reported Medicaid activity (SDUD)839,166 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Allopurinol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Allopurinol lowers uric acid. The tablets are used for gout, for high uric acid caused by cancer treatment, and for recurrent calcium oxalate kidney stones in certain adults. The I...
- No. Flares can happen early as uric acid shifts, and it can take months to settle. Your doctor will likely suggest colchicine or an anti-inflammatory to help prevent them. Keep tak...
- I got a gout flare after starting it. Should I stop?
- Nausea, diarrhea and mild changes in liver tests are the most common. A skin rash is the one to take seriously. Stop the medicine and get medical help right away if a rash or aller...
🕸️ Concept Web — How Allopurinol 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Allopurinol 100 MG Oral Tablet
RxCUI 197319 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Allopurinol
519IN
-
Allopurinol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zyloprim
203600BN
-
Zyloprim
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Allopurinol Oral Tablet
370547SCDF -
Allopurinol Oral Product
1154941SCDG -
Allopurinol Pill
1154942SCDG -
Allopurinol Oral Tablet [Zyloprim]
368113SBDF -
Zyloprim Oral Product
1186496SBDG -
Zyloprim Pill
1186497SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Allopurinol Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Allopurinol 100 MG
315310SCDC -
Allopurinol 100 MG Oral Tablet [Zyloprim]
213995SBD -
Allopurinol 100 MG [Zyloprim]
573839SBDC
-
Allopurinol 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Allopurinol 100 MG
SCDC · 315310 -
Allopurinol Oral Tablet
SCDF · 370547 -
Allopurinol Oral Product
SCDG · 1154941 -
Allopurinol Pill
SCDG · 1154942
Brand-Name Concepts
-
Allopurinol 100 MG Oral Tablet [Zyloprim]
SBD · 213995 -
Allopurinol 100 MG [Zyloprim]
SBDC · 573839 -
Allopurinol Oral Tablet [Zyloprim]
SBDF · 368113 -
Zyloprim Oral Product
SBDG · 1186496 -
Zyloprim Pill
SBDG · 1186497 -
Zyloprim
BN · 203600
📦 FDA Products & Package NDCs
104 products · 265 package NDCs
265 package NDCs map to RxCUI 197319 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-0137-01 | 100 TABLET in 1 BOTTLE (0378-0137-01) | Allopurinol | Mylan Pharmaceuticals Inc. | 1986-10-24 |
| 00378-0137-10 | 1000 TABLET in 1 BOTTLE (0378-0137-10) | Allopurinol | Mylan Pharmaceuticals Inc. | 1986-10-24 |
| 00378-0181-01 | 100 TABLET in 1 BOTTLE (0378-0181-01) | Allopurinol | Mylan Pharmaceuticals Inc. | 1986-10-24 |
| 00378-0181-05 | 500 TABLET in 1 BOTTLE (0378-0181-05) | Allopurinol | Mylan Pharmaceuticals Inc. | 1986-10-24 |
| 00591-5543-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-5543-10) | Allopurinol | Actavis Pharma, Inc. | 2009-04-06 |
| 00591-5544-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5544-01) | Allopurinol | Actavis Pharma, Inc. | 2009-04-06 |
| 00591-5544-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5544-05) | Allopurinol | Actavis Pharma, Inc. | 2009-04-06 |
| 00603-2115-21 | 100 TABLET in 1 BOTTLE, PLASTIC (0603-2115-21) | Allopurinol | Par Health USA, LLC | 2003-06-27 |
| 00603-2115-32 | 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2115-32) | Allopurinol | Par Health USA, LLC | 2003-06-27 |
| 00603-2116-21 | 100 TABLET in 1 BOTTLE, PLASTIC (0603-2116-21) | Allopurinol | Par Health USA, LLC | 2003-06-27 |
| 00603-2116-28 | 500 TABLET in 1 BOTTLE, PLASTIC (0603-2116-28) | Allopurinol | Par Health USA, LLC | 2003-06-27 |
| 00603-2116-32 | 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2116-32) | Allopurinol | Par Health USA, LLC | 2003-06-27 |
| 00615-8385-05 | 15 TABLET in 1 BLISTER PACK (0615-8385-05) | Allopurinol | NCS HealthCare of KY, LLC dba Vangard Labs | 2021-02-09 |
| 00615-8385-39 | 30 TABLET in 1 BLISTER PACK (0615-8385-39) | Allopurinol | NCS HealthCare of KY, LLC dba Vangard Labs | 2021-02-09 |
| 00615-8517-05 | 15 TABLET in 1 BLISTER PACK (0615-8517-05) | Allopurinol | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-08-13 |
| 00615-8517-39 | 30 TABLET in 1 BLISTER PACK (0615-8517-39) | Allopurinol | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-08-13 |
| 00904-7041-61 | 100 BLISTER PACK in 1 CARTON (0904-7041-61) / 1 TABLET in 1... | Allopurinol | Major Pharmaceuticals | 2018-02-08 |
| 14445-0170-00 | 1000 TABLET in 1 BOTTLE (14445-170-00) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0170-01 | 100 TABLET in 1 BOTTLE (14445-170-01) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0170-05 | 500 TABLET in 1 BOTTLE (14445-170-05) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0170-30 | 30 TABLET in 1 BOTTLE (14445-170-30) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0171-00 | 1000 TABLET in 1 BOTTLE (14445-171-00) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0171-01 | 100 TABLET in 1 BOTTLE (14445-171-01) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0171-05 | 500 TABLET in 1 BOTTLE (14445-171-05) | Allopurinol | Indoco Remedies Limited | 2016-07-28 |
| 14445-0172-00 | 1000 TABLET in 1 BOTTLE (14445-172-00) | Allopurinol | Indoco Remedies Limited | 2025-05-22 |
| 14445-0172-01 | 100 TABLET in 1 BOTTLE (14445-172-01) | Allopurinol | Indoco Remedies Limited | 2025-05-22 |
| 14445-0172-05 | 500 TABLET in 1 BOTTLE (14445-172-05) | Allopurinol | Indoco Remedies Limited | 2025-05-22 |
| 14445-0172-10 | 10 BLISTER PACK in 1 CARTON (14445-172-10) / 10 TABLET in 1... | Allopurinol | Indoco Remedies Limited | 2025-02-04 |
| 14445-0172-90 | 90 TABLET in 1 BOTTLE (14445-172-90) | Allopurinol | Indoco Remedies Limited | 2025-05-22 |
| 16571-0883-01 | 100 TABLET in 1 BOTTLE (16571-883-01) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0883-09 | 90 TABLET in 1 BOTTLE (16571-883-09) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0883-10 | 1000 TABLET in 1 BOTTLE (16571-883-10) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0883-50 | 500 TABLET in 1 BOTTLE (16571-883-50) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0884-01 | 100 TABLET in 1 BOTTLE (16571-884-01) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0884-09 | 90 TABLET in 1 BOTTLE (16571-884-09) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0884-10 | 1000 TABLET in 1 BOTTLE (16571-884-10) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0884-50 | 500 TABLET in 1 BOTTLE (16571-884-50) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0885-01 | 100 TABLET in 1 BOTTLE (16571-885-01) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0885-09 | 90 TABLET in 1 BOTTLE (16571-885-09) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0885-10 | 1000 TABLET in 1 BOTTLE (16571-885-10) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16571-0885-50 | 500 TABLET in 1 BOTTLE (16571-885-50) | Allopurinol | Rising Pharma Holdings, Inc. | 2023-09-21 |
| 16714-0576-01 | 30 TABLET in 1 BOTTLE (16714-576-01) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16714-0576-02 | 100 TABLET in 1 BOTTLE (16714-576-02) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16714-0576-03 | 500 TABLET in 1 BOTTLE (16714-576-03) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16714-0576-04 | 1000 TABLET in 1 BOTTLE (16714-576-04) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16714-0577-01 | 100 TABLET in 1 BOTTLE (16714-577-01) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16714-0577-02 | 500 TABLET in 1 BOTTLE (16714-577-02) | Allopurinol | NorthStar RxLLC | 2022-07-01 |
| 16729-0134-01 | 100 TABLET in 1 BOTTLE (16729-134-01) | Allopurinol | Accord Healthcare Inc. | 2015-04-29 |
| 16729-0134-16 | 500 TABLET in 1 BOTTLE (16729-134-16) | Allopurinol | Accord Healthcare Inc. | 2016-06-14 |
| 16729-0135-01 | 100 TABLET in 1 BOTTLE (16729-135-01) | Allopurinol | Accord Healthcare Inc. | 2015-04-29 |
Observed labelers:
Bryant Ranch Prepack (50) ·
Preferred Pharmaceuticals Inc. (16) ·
A-S Medication Solutions (15) ·
Aphena Pharma Solutions - Tennessee, LLC (15) ·
Indoco Remedies Limited (12) ·
Rising Pharma Holdings, Inc. (12)
· +32 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.